Mackenzie Financial’s Blueprint Medicines BPMC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $513K | Sell |
4,001
-12,195
| -75% | -$1.56M | ﹤0.01% | 1225 |
|
|
2025
Q1 | $1.43M | Buy |
16,196
+2,019
| +14% | +$179K | ﹤0.01% | 875 |
|
|
2024
Q4 | $1.24M | Buy |
14,177
+7,076
| +100% | +$617K | ﹤0.01% | 892 |
|
|
2024
Q3 | $657K | Buy |
7,101
+2,216
| +45% | +$205K | ﹤0.01% | 958 |
|
|
2024
Q2 | $527K | Buy |
4,885
+243
| +5% | +$26.2K | ﹤0.01% | 1002 |
|
|
2024
Q1 | $440K | Buy |
4,642
+170
| +4% | +$16.1K | ﹤0.01% | 1047 |
|
|
2023
Q4 | $412K | Hold |
4,472
| – | – | ﹤0.01% | 1051 |
|
|
2023
Q3 | $217K | Hold |
4,472
| – | – | ﹤0.01% | 1250 |
|
|
2023
Q2 | $281K | Hold |
4,472
| – | – | ﹤0.01% | 1190 |
|
|
2023
Q1 | $201K | Buy |
+4,472
| New | +$201K | ﹤0.01% | 1341 |
|
|
2022
Q4 | – | Sell |
-5,796
| Closed | -$382K | – | 1452 |
|
|
2022
Q3 | $382K | Buy |
5,796
+1,561
| +37% | +$103K | ﹤0.01% | 1011 |
|
|
2022
Q2 | $214K | Buy |
4,235
+886
| +26% | +$44.8K | ﹤0.01% | 1252 |
|
|
2022
Q1 | $214K | Buy |
3,349
+169
| +5% | +$10.8K | ﹤0.01% | 1262 |
|
|
2021
Q4 | $341K | Sell |
3,180
-5,019
| -61% | -$538K | ﹤0.01% | 1101 |
|
|
2021
Q3 | $843K | Buy |
8,199
+1,573
| +24% | +$162K | ﹤0.01% | 933 |
|
|
2021
Q2 | $583K | Buy |
+6,626
| New | +$583K | ﹤0.01% | 954 |
|
|
2016
Q3 | – | Sell |
-23,800
| Closed | -$482K | – | 676 |
|
|
2016
Q2 | $482K | Buy |
23,800
+1,700
| +8% | +$34.4K | ﹤0.01% | 762 |
|
|
2016
Q1 | $399K | Buy |
22,100
+7,600
| +52% | +$137K | ﹤0.01% | 688 |
|
|
2015
Q4 | $382K | Buy |
+14,500
| New | +$382K | ﹤0.01% | 710 |
|